Neurocrine appoints Dr. Eiry Roberts as new Chief Medical Officer, effective September 28, 2026
What happened
3 signals in this filing. The 'mutually agreed' departure of the former CMO, Dr.
Source
Extracted by Autobound
From the Signal API record- Signal
- SEC 8-K
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Filed
- Sep 28, 2026
More SEC 8-K signals at other companies
- SEC 8-K4D Molecular Therapeutics, Inc.4D Molecular Therapeutics initiates Phase 3 trial directly challenging competitor drug aflibercept.SEC 8-K
- SEC 8-KAdeia Inc.Adeia Inc. appoints new CEO Dipti Vachani, effective October 12, 2026, replacing outgoing CEO Paul E. Davis.SEC 8-K
- SEC 8-KAdicet Bio, Inc.Adicet Bio launching pivotal clinical trial in Q4 2026 after positive Phase 1 data for Prula-cel.SEC 8-K
The full record
From the Signal API recordNumbers
- Dollar figureTotal target value of new equity grants (options, RSUs, performance units) for the incoming Chief Medical Officer.
- $1.3M
- PercentTarget annual cash incentive bonus as a percentage of base pay for the new Chief Medical Officer.
- 0.6%
Details
- CIK
- 914475
- Accession number
- 0000914475-26-000045
- Timeframe
- Immediate
- Filing year
- 2026
- Fiscal year end
- 09/25
- Why it matters
- Clinical/R&D vendor review
- Signal category
- Leadership
Topics and mentions
Events in the filing
- Chief medical officer change
- Governance change
- Restructuring
Tags
- chiefMedicalOfficerChange
- governanceChange
- restructuring
Extraction
- Confidence
- High
- Relevance
- 100%
- Sentiment
- Neutral
- Detected
- Sep 29, 2026
- signal_type
sec-8k- signal_subtype
chiefMedicalOfficerChange
Use this data
Get every SEC 8-K signal for Neurocrine Biosciences, Inc. and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Neurocrine Biosciences, Inc. this week?”
Send it to your own tools
The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/9855ec3b-fb37-415c-bba6-5a54e3710eab returns this record as JSON. POST /v1/companies/enrich returns every signal for neurocrine.com.
{
"signal_id": "9855ec3b-fb37-415c-bba6-5a54e3710eab",
"signal_type": "sec-8k",
"signal_subtype": "chiefMedicalOfficerChange",
"detected_at": "2026-09-29T08:10:50.006+00:00",
"company": {
"name": "Neurocrine Biosciences, Inc.",
"domain": "neurocrine.com"
},
"data": {
"detail": "The appointment of a new Chief Medical Officer signals a potential shift in clinical development strategy and creates a 90-day window for vendors to engage new leadership. Existing clinical trial, data management, and medical affairs vendor relationships will likely be reviewed.",
"metrics": {
"pct": 0.6,
"timeframe": "immediate",
"pct_context": "Target annual cash incentive bonus as a percentage of base pay for the new Chief Medical Officer.",
"dollar_context": "Total target value of new equity grants (options, RSUs, performance units) for the incoming Chief Medical Officer.",
"dollar_millions": 1.25
},
"summary": "Neurocrine appoints Dr. Eiry Roberts as new Chief Medical Officer, effective September 28, 2026",
"relevance": 1,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/914475/000091447526000045/nbix-20260925.htm",
"filing_date": "2026-09-28",
"filing_year": 2026,
"fiscal_year_end": "09/25",
"sales_relevance": "Clinical/R&D vendor review",
"signal_category": "leadership"
}
}
curl https://signals.autobound.ai/v1/signals/9855ec3b-fb37-415c-bba6-5a54e3710eab \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"neurocrine.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.